Minze Health

Minze Health is a digital health company that provides home-based diagnostics and therapeutics for lower urinary tract symptoms (LUTS/BPH) and overactive bladder (OAB). The company's platform integrates in-clinic and home-based uroflowmetry, automated bladder diaries, and digital therapy. Its key products include Homeflow, a portable Bluetooth-connected uroflowmeter combining uroflowmetry, bladder diary, and IPSS scoring; Diary Pod, an automated bladder diary; and a 13-week app-based digital behavioral therapy program. The company targets nearly 80 million adults in the U.S. and over 90 million in the EU affected by LUTS. Founded in 2015 and headquartered in Antwerp, Belgium, Minze Health is ISO 13485:2016 certified and has raised approximately $9.5 million in Series A funding from investors including imec.istart, Capricorn Partners, PMV, and White Fund.